Primary lymphedema: Clinical features and management in 138 pediatric patients

Plastic and Reconstructive Surgery

Volumn 127, Issue 6, 2011, Pages 2419-2431

  Schook, Carolyn C ^a   Mulliken, John B ^a   Fishman, Steven J ^a   Grant, Frederick D ^a   Zurakowski, David ^a   Greene, Arin K ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; GENITAL SYSTEM DISEASE; HUMAN; INFANT; LIMB; LYMPHEDEMA; MALE; ONSET AGE; PRESCHOOL CHILD;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; EXTREMITIES; FEMALE; GENITAL DISEASES, MALE; HUMANS; INFANT; LYMPHEDEMA; MALE; YOUNG ADULT;

EID: 79958758670     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318213a218     Document Type: Article

References (77)

1. Brorson H. Adipose tissue in lymphedema: The ignorance of adipose tissue in lymphedema. Lymphology 2004;37:175-177. (Pubitemid 40082898)
2. Lymphatic filariasis: Fourth report of the WHO Expert Committee on Filariasis. World Health Organ Tech Rep Ser. 1984; 702:3-112.
3. Rockson SG, Rivera KK. Estimating the population burden of lymphedema. Ann NY Acad Sci. 2008;1131:147-154. (Pubitemid 351760885)
4. Smeltzer DM, Stickler GB, Schirger A. Primary lymphedema in children and adolescents: A follow-up study and review. Pediatrics 1985;76:206-218. (Pubitemid 15039904)
5. Kinmonth JB, Taylor GW, Tracy GD, Marsh JD. Primary lymphoedema; clinical and lymphangiographic studies of a series of 107 patients in which the lower limbs were affected. Br J Surg. 1957;45:1-9.
6. Gough MH. Primary lymphoedema: Clinical and lymphangiographic studies. Br J Surg. 1966;53:917-925.
7. Saijo M, Munro IR, Mancer K. Lymphedema: A clinical review and follow-up study. Plast Reconstr Surg. 1975;56:513-521.
8. O'Brien BM, Das SK, Franklin JD, Morrison WA. Effect of lymphangiography on lymphedema. Plast Reconstr Surg. 1981; 68:922-926. (Pubitemid 12237510)
9. Lewis JM, Wald ER. Lymphedema praecox. J Pediatr. 1984; 104:641-648. (Pubitemid 14111022)
10. Browse NL. The diagnosis and management of primary lymphedema. J Vasc Surg. 1986;3:181-184.
11. Hilliard RI, McKendry JB, Phillips MJ. Congenital abnormalities of the lymphatic system: A new clinical classification. Pediatrics 1990;86:988-994.
12. Herman-Giddens ME, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: A study from the Pediatric Research in Office Settings network. Pediatrics 1997;99:505-512.
13. Irwin CE, Shafer M, Moscicki A. The adolescent patient. In: Rudolph AM, Rudolph CD, Hostetter MK, Lister G, Siegel NJ, eds. Rudolph's Pediatrics. 21st ed. New York: McGraw-Hill; 2003:223.
14. Lee PA. Normal ages of pubertal events among American males and females. J Adolesc Health Care 1980;1:26-29. (Pubitemid 11176546)
15. Liu AS, Mulliken JB, Zurakowski D, Fishman SJ, Greene AK. Extracranial arteriovenous malformations: Natural progression and recurrence after treatment. Plast Reconstr Surg. 2010; 125:1185-1194.
16. Nonne M. Vier Fälle von Elephantiasis congenita hereditaria. Virchows Arch Pathol Anat Physiol Klin Med. 1891:189-196.
17. Milroy W. An undescribed variety of hereditary oedema. NY Med J. 1892;56:505-508.
18. Milroy W. Chronic hereditary edema: Milroy's disease. JAMA 1928;91:1172-1175.
19. Brouillard P, Vikkula M. Genetic causes of vascular malformations. Hum Mol Genet. 2007;16:R140-R149.
20. Connell FC, Ostergaard P, Carver C, et al. Analysis of the coding regions of VEGFR3 and VEGFC in Milroy disease and other primary lymphoedemas. Hum Genet. 2009;124: 625-631.
21. Meige H. Dystrophie oedematose hereditaire. Presse Med. 1898;6:341-343.
22. Goodman R. Familial lymphedema of the Meige's type. Am J Med. 1962;32:651-656.
23. Fang J, Dagenais SL, Erickson RP, et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet. 2000;67:1382-1388.
24. Erickson RP, Dagenais SL, Caulder MS, et al. Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations. J Med Genet. 2001;38:761-766. (Pubitemid 33032931)
25. Falls HF, Kertesz ED. A new syndrome combining pterygium colli with developmental anomalies of the eyelids and lymphatics of the lower extremities. Trans Am Ophthalmol Soc. 1964;62:248-275.
26. Hennekam RC, Geerdink RA, Hamel BC, et al. Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation. Am J Med Genet. 1989;34:593-600. (Pubitemid 20033591)
27. Alders M, Hogan BM, Gjini E, et al. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet. 2009;41:1272-1274.
28. Turner H. A syndrome of infantilism, congenital webbed neck, and cubitus valgus. Endocrinology 1938;23:566-574.
29. Noonan JA. Hypertelorism with Turner phenotype: A new syndrome with associated congenital heart disease. Am J Dis Child. 1968;116:373-380.
30. Tartaglia M, Mehler EL, Goldberg R, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29:465-468. (Pubitemid 34326699)
31. Wiedemann HR, Glatzl J. Follow-up of Ullrich's original patient with "Ullrich-Turner" syndrome. Am J Med Genet. 1991; 41:134-136.
32. Loscalzo ML. Turner syndrome. Pediatr Rev. 2008;29:219-227.
33. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg. 1982; 69:412-422. (Pubitemid 12191292)
34. Rudkin GH, Miller TA. Lipedema: A clinical entity distinct from lymphedema. Plast Reconstr Surg. 1994;94:841-847; discussion 848-849.
35. Greene AK, Karnes J, Padua HM, Schmidt BA, Kasser JR, Labow BI. Diffuse lipofibromatosis of the lower extremity masquerading as a vascular anomaly. Ann Plast Surg. 2009; 62:703-706.
36. Alomari AI. Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: A descriptive study of 18 cases of CLOVES syndrome. Clin Dysmorphol. 2009;18:1-7.
37. Allen E. Lymphedema of the extremities. Arch Intern Med. 1934;56:606-624.
38. Wolfe JH, Kinmonth JB. The prognosis of primary lymphedema of the lower limbs. Arch Surg. 1981;116:1157-1160. (Pubitemid 11049345)
39. Schirger A. Postoperative lymphedema: Etiologic and diagnostic factors. Med Clin North Am. 1962;46:1045-1050.
40. Brunner U. Natural history of primary lymphedema of the legs. Pathol Microbiol (Basel) 1975;43:230-234.
41. Fonkalsrud EW. A syndrome of congenital lymphedema of the upper extremity and associated systemic lymphatic malformations. Surg Gynecol Obstet. 1977;145:228-234. (Pubitemid 8210139)
42. Levine C. Primary disorders of the lymphatic vessels: A unified concept. J Pediatr Surg. 1989;24:233-240. (Pubitemid 19070437)
43. Wright NB, Carty HM. The swollen leg and primary lymphoedema. Arch Dis Child. 1994;71:44-49. (Pubitemid 24238523)
44. Browse NL, Stewart G. Lymphoedema: Pathophysiology and classification. J Cardiovasc Surg. 1985;26:91-106. (Pubitemid 15079963)
45. Fonkalsrud E, Coulson W. Management of congenital lymphedema in infants and children. Ann Surg. 1973;177: 280-285.
46. Schirger A, Harrison EG Jr, Janes JM. Idiopathic lymphedema: Review of 131 cases. JAMA 1962;182:14-22.
47. Brice G, Child AH, Evans A, et al. Milroy disease and the VEGFR-3 mutation phenotype. J Med Genet. 2005;42:98-102. (Pubitemid 40204362)
48. Ghalamkarpour A, Holnthoner W, Saharinen P, et al. Recessive primary congenital lymphoedema caused by a VEGFR3 mutation. J Med Genet. 2009;46:399-404.
49. Karkkainen MJ, Ferrell RE, Lawrence EC, et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet. 2000;25:153-159. (Pubitemid 30394984)
50. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet. 2000;67:295-301. (Pubitemid 30616736)
51. Ghalamkarpour A, Morlot S, Raas-Rothschild A, et al. Hereditary lymphedema type I associated with VEGFR3 mutation: The first de novo case and atypical presentations. Clin Genet. 2006;70:330-335. (Pubitemid 44323399)
52. Carver C, Brice G, Mansour S, et al. Three children with Milroy disease and de novo mutations in VEGFR3. Clin Genet. 2007;71:187-189. (Pubitemid 46189225)
53. Connell F, Brice G, Jeffery S, Keeley V, Mortimer P, Mansour S. A new classification system for primary lymphatic dysplasias based on phenotype. Clin Genet. 2010;77:438-452.
54. Rezaie T, Ghoroghchian R, Bell R, et al. Primary non-syndromic lymphoedema (Meige disease) is not caused by mutations in FOXC2. Eur J Hum Genet. 2008;16:300-304. (Pubitemid 351292229)
55. Moffatt CJ, Franks PJ, Doherty DC, et al. Lymphoedema: An underestimated health problem. QJM. 2003;96:731-738. (Pubitemid 37259362)
56. Stewart F, Treves N. Lymphangiosarcoma in postmastectomy lymphedema; a report of six cases in elephantiasis chirurgica. Cancer 1948;1:64-81.
57. Stemmer R. A clinical symptom for the early and differential diagnosis of lymphedema (in German). Vasa 1976; 5:261-262.
58. Stemmer R. Stemmer's sign: Possibilities and limits of clinical diagnosis of lymphedema (in German). Wien Med Wochenschr. 1999;149:85-86. (Pubitemid 29197573)
59. Gloviczki P, Calcagno D, Schirger A, et al. Noninvasive evaluation of the swollen extremity: Experiences with 190 lymphoscintigraphic examinations. J Vasc Surg. 1989;9:683-689; discussion 690.
60. Szuba A, Shin WS, Strauss HW, Rockson S. The third circulation: Radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44:43-57. (Pubitemid 36077712)
61. Brorson H, Svensson H. Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone. Plast Reconstr Surg. 1998;102:1058-1067; discussion 1068. (Pubitemid 128723394)
62. Schmitz KH, Ahmed RL, Troxel A, et al. Weight lifting in women with breast-cancer-related lymphedema.NEngl J Med. 2009;361:664-673.
63. Moseley AL, Carati CJ, Piller NB. A systematic review of common conservative therapies for arm lymphoedema secondary to breast cancer treatment. Ann Oncol. 2007; 18:639-646. (Pubitemid 46523265)
64. Andersen L, Højris I, Erlandsen M, Andersen J. Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage: A randomized study. Acta Oncol. 2000;39:399-405. (Pubitemid 30643089)
65. Williams AF, Vadgama A, Franks PJ, Mortimer PS. A randomized controlled crossover study of manual lymphatic drainage therapy in women with breast cancer-related lymphoedema. Eur J Cancer Care (Engl.) 2002;11:254-261.
66. Bergan J, Sparks S, Angle N. A comparison of compression pumps in the treatment of lymphedema. Vasc Surg. 1998;32: 455-462.
67. Richmand DM, O'Donnell TF Jr, Zelikovski A. Sequential pneumatic compression for lymphedema: A controlled trial. Arch Surg. 1985;120:1116-1119. (Pubitemid 16229683)
68. Tiwari A, Cheng KS, Button M, Myint F, Hamilton G. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg. 2003;138:152-161. (Pubitemid 36216279)
69. Szuba A, Rockson SG. Lymphedema: Classification, diagnosis and therapy. Vasc Med. 1998;3:145-156. (Pubitemid 28481265)
70. Casley-Smith JR, Casley-Smith JR. Frequency of coumarin hepatotoxicity. Med J Aust. 1995;162:391-395.
71. Loprinzi CL, Sloan J, Kugler J. Coumarin-induced hepatotoxicity. J Clin Oncol. 1997;15:3167-3168.
72. Miller TA, Wyatt LE, Rudkin GH. Staged skin and subcutaneous excision for lymphedema: A favorable report of longterm results. Plast Reconstr Surg. 1998;102:1486-1498; discussion 1499-1501. (Pubitemid 28468689)
73. O'Brien BM, Mellow CG, Khazanchi RK, Dvir E, Kumar V, Pederson WC. Long-term results after microlymphaticovenous anastomoses for the treatment of obstructive lymphedema. Plast Reconstr Surg. 1990;85:562-572. (Pubitemid 20136882)
74. Goldsmith HS. Long term evaluation of omental transposition for chronic lymphedema. Ann Surg. 1974;180:847-849.
75. Greene AK, Slavin SA, Borud L. Treatment of lower extremity lymphedema with suction-assisted lipectomy. Plast Reconstr Surg. 2006;118:118e-121e. (Pubitemid 44511396)
76. Brorson H, Ohlin K, Olsson G, Svensson B, Svensson H. Controlled compression and liposuction treatment for lower extremity lymphedema. Lymphology 2008;41: 52-63. (Pubitemid 352031245)
77. Miller TA. Charles procedure for lymphedema: A warning. Am J Surg. 1980;139:290-292. (Pubitemid 10174753)